Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 1466

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 9B
Chunk 1466
---
     (d)  
     (e)  
     (f)  
     (h) 
  
     2025  
    $–  
    $–  
    $500,000  
    $495,402  
    $430,844  
    $430,875  
    $2.45  
    $(13.40)
  
     2024  
    $505,332  
    $395,249  
    $416,449  
    $400,496  
    $404,032  
    $385,270  
    $8.28  
    $(12.21)
  
     2023  
    $460,000  
    $(62,027) 
     –  
     –  
    $388,750  
    $220,700  
    $18.84  
    $(12.03)

    (1)
    The dollar amounts reported in these columns (b) are the amounts of total compensation reported for our respective PEOs for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Executive Compensation — Summary Compensation Table.”

    (2)
    Charles J. Fisher, Jr., M.D. served as the Company’s Chief Executive Officer for the entirety of the year fiscal year ended March 31, 2023 and through November 7, 2023, and served as the Company’s PEO for such period.

    (3)
    James B. Frakes was appointed as the Company’s Chief Executive Officer, effective November 7, 2023, and served as the Company’s PEO from such date through March 31, 2024.

    (4)
    The dollar amounts reported in columns (c) represent the amount of “compensation actually paid” to Dr. Fisher and Mr. Frakes in the periods during which they served as PEO, respectively, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to our PEOs during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to the reported total compensation for our PEOs for each year to determine the compensation actually paid:

 73 

    PEO
    1  
    PEO